| Cáncer de pulmón no microcítico, Carcinoma hepatocelular NCT03916627 | Fase 2 | En marcha, sin reclutar |
| Carcinoma escamoso cutáneo NCT04050436 | Fase 2 | En marcha, sin reclutar |
| Melanoma NCT06190951 | Fase 2 | En marcha, sin reclutar |
| Cáncer de pulmón no microcítico NCT06465329 | Fase 2 | En marcha, sin reclutar |
| Tumores malignos avanzados NCT03233139 | Fase 1 | En marcha, sin reclutar |
| Carcinoma escamoso cutáneo NCT03969004 | Fase 3 | En marcha, sin reclutar |
| Cáncer de pulmón no microcítico NCT05363319 | no aplica | Reclutando pacientes |
| Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma NCT06585410 | Fase 3 | Reclutando pacientes |
| Cáncer epitelial de ovario, Carcinoma peritoneal primario NCT06469281 | Fase 1 | Reclutando pacientes |
| A Study Comparing Cemiplimab-based Treatments for Adult Participants With Locally Advanced Basal Cell Skin Cancer (laBCC) NCT07808515 | Fase 2 | Aún sin reclutar |
| A Safety and Efficacy Study of Combined Fianlimab + Cemiplimab in Children and Young Adults With Recurrent or Progressive High-Grade Glioma or Posterior Fossa-A Ependymoma NCT07567469 | Fase 1/2 | Aún sin reclutar |
| Carcinoma escamoso cutáneo NCT06384820 | Fase 2 | Retirado antes de empezar |
| CLIO-1 NCT02651662 | Fase 1 | Completado |
| Carcinoma escamoso cutáneo NCT03889912 | Fase 1 | Completado |
| Carcinoma escamoso cutáneo NCT03836105 | no aplica | Completado |
| Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma NCT02760498 | Fase 2 | Completado |
| Cáncer de cuello de útero NCT04646005 | Fase 2 | Completado |
| REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma NCT03690869 | Fase 1/2 | Interrumpido |
| Anti-PD-1 Antibody Treatment With Cemiplimab and Radiotherapy in Early-stage Classical Hodgkin Lymphoma NCT04373083 | Fase 2 | Retirado antes de empezar |
| Carcinoma escamoso cutáneo NCT04154943 | Fase 2 | Completado |
| PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy NCT03132636 | Fase 2 | Completado |
| Study of Cemiplimab in Adults With Cervical Cancer NCT03257267 | Fase 3 | Completado |
| Cáncer avanzado, Tumores malignos avanzados NCT02383212 | Fase 1 | Completado |
| Carcinoma escamoso cutáneo NCT03492489 | no aplica | Ya no disponible |
| Cáncer de pulmón no microcítico NCT06132191 | no aplica | Aprobado para comercializar |